Pediatric Vaccine Market to Witness Significant Growth of USD $62.48 Billion with 7.4% CAGR by 2029

 Get 20% Off Market Intelligence Reports With Code ONLINE20 — Track Global Tariffs, Economic Shifts, and Sector Transformations

 

 How Does the Projected Market Size of the Pediatric Vaccine Market Compare to 2025 Levels?
 The pediatric vaccine market size has grown strongly in recent years. It will grow from $44.2 billion in 2024 to $46.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, immunization policies to eradicate endemic diseases, increased funding for vaccine development.
 
 The pediatric vaccine market size is expected to see strong growth in the next few years. It will grow to $62.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing cases of invasive cervical cancer, strong late-stage pipeline and new drug approvals, increasing prevalence of infectious diseases. Major trends in the forecast period include developing combination vaccines to meet market demand, consider investing R&D activities for the development of effective vaccines, focusing on developing live attenuated vaccines, utilizing new immune engineering and advance delivery systems and implementing artificial intelligence (AI) in vaccine development to simplify the process and make manufacturing easy.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp
  
 What Are the Key Factors Contributing to Pediatric Vaccine Market Growth?
 The rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory body entrusted with gathering and evaluating data and providing factual recommendations, about half of the overall population (46.6%, or 11.6 million) had at least one chronic condition. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the growth of the pediatric vaccine market. 
 
 What Are the Core Segments Shaping the Pediatric Vaccine Market Landscape?
 The pediatric vaccine market covered in this report is segmented — 
 
 1) By Vaccine Type: Monovalent, Multivalent 
 2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
 3) By Application: Infectious Disease, Allergy, Cancer
 
 Subsegments:
 1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines 
 2) By Multivalent: Combination Vaccines, Polyvalent Vaccines
 
 What Are the Key Industry Trends Transforming the Pediatric Vaccine Market?
 The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g., tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for the innovation of vaccine design and manufacturing technologies. For instance, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company announced the U.S. FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants. 
 
 Which Players Dominate the Pediatric Vaccine Market Landscape?
 Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium 
 
 Get the full pediatric vaccine market report here:
 https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
 
 What Are the Regional Insights for the Pediatric Vaccine Market Forecast?
 North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company